Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Charles Mullighan & James Downing. (2008) Ikaros and acute leukemia. Leukemia & Lymphoma 49:5, pages 847-849.
Read now
Read now
Articles from other publishers (20)
Adele Mucci, Gabriele Antonarelli, Carolina Caserta, Francesco Maria Vittoria, Giacomo Desantis, Riccardo Pagani, Beatrice Greco, Monica Casucci, Giulia Escobar, Laura Passerini, Nico Lachmann, Francesca Sanvito, Matteo Barcella, Ivan Merelli, Luigi Naldini & Bernhard Gentner. (2021) Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses. EMBO Molecular Medicine 13:10.
Crossref
Crossref
Jason H. Rogers, Rohit Gupta, Jaime M. Reyes, Michael Gundry, Geraldo Medrano, Anna Guzman, Rogelio Aguilar, Shannon E. Conneely, Tidie Song, Cade Anthony Johnson, Sean Barnes, Carlo D.D. Cristobal, Kristen Kurtz, Lorenzo Brunetti, Margaret A Goodell & Rachel E. Rau. (2021)
Modeling
IKZF1
lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities
. Blood Advances.
Crossref
Crossref
Sana Mahjoub, Vera Chayeb, Hedia Zitouni, Rabeb M. Ghali, Haifa Regaieg, Wassim Y. Almawi & Touhami Mahjoub. (2019) IKZF1 genetic variants rs4132601 and rs11978267 and acute lymphoblastic leukemia risk in Tunisian children: a case-control study. BMC Medical Genetics 20:1.
Crossref
Crossref
Changfeng Shao, Jie Yang, Yirong Kong, Cong Cheng, Wei Lu, Hongzai Guan & Haiyan Wang. (2017) Overexpression of dominant-negative Ikaros 6 isoform is associated with resistance to TKIs in patients with Philadelphia chromosome positive acute lymphoblastic leukemia. Experimental and Therapeutic Medicine 14:4, pages 3874-3879.
Crossref
Crossref
Juan Han, Runming Jin, Meiling Zhang, Qing Guo & Fen Zhou. (2017) Ikaros 6 protects acute lymphoblastic leukemia cells against daunorubicin-induced apoptosis by activating the Akt-FoxO1 pathway. Journal of Leukocyte Biology 101:3, pages 675-681.
Crossref
Crossref
Xiaojing Lin, Xingli Zou, Ziming Wang, Qin Fang, Shuya Chen, Jun Huang, Nana Zhe, Meisheng Yu, Yaming Zhang & Jishi Wang. (2016) Targeting of heme oxygenase-1 attenuates the negative impact of Ikaros isoform 6 in adult BCR-ABL1-positive B-ALL. Oncotarget 7:33, pages 53679-53701.
Crossref
Crossref
Sofia von Palffy, Elizabeth Bulaeva, Sonja Babovic, Nagarajan Kannan, David J.H.F. Knapp, Lisa Wei, Connie J. Eaves & Philip A. Beer. (2015) Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1+ mouse BA/F3 cells. Experimental Hematology 43:7, pages 514-523.e2.
Crossref
Crossref
Linda Olsson & Bertil Johansson. (2015) Ikaros and leukaemia. British Journal of Haematology 169:4, pages 479-491.
Crossref
Crossref
Nicole C. C. Them & Robert Kralovics. (2013) Genetic Basis of MPN: Beyond JAK2-V617F. Current Hematologic Malignancy Reports 8:4, pages 299-306.
Crossref
Crossref
Satomi Asanuma, Makoto Yamagishi, Katsuaki Kawanami, Kazumi Nakano, Aiko Sato-Otsubo, Satsuki Muto, Masashi Sanada, Tadanori Yamochi, Seiichiro Kobayashi, Atae Utsunomiya, Masako Iwanaga, Kazunari Yamaguchi, Kaoru Uchimaru, Seishi Ogawa & Toshiki Watanabe. (2013)
Adult T-cell leukemia cells are characterized by abnormalities of
Helios
expression that promote T cell growth
. Cancer Science 104:8, pages 1097-1106.
Crossref
Crossref
Daria Capece, Francesca Zazzeroni, Maria Michela Mancarelli, Daniela Verzella, Mariafausta Fischietti, Ambra Di Tommaso, Rita Maccarone, Sara Plebani, Mauro Di Ianni, Alberto Gulino & Edoardo Alesse. (2013) A Novel, Non-canonical Splice Variant of the Ikaros Gene Is Aberrantly Expressed in B-cell Lymphoproliferative Disorders. PLoS ONE 8:7, pages e68080.
Crossref
Crossref
Jelena D. Milosevic & Robert Kralovics. (2012) Genetic and epigenetic alterations of myeloproliferative disorders. International Journal of Hematology 97:2, pages 183-197.
Crossref
Crossref
Ilaria Iacobucci, Nunzio Iraci, Monica Messina, Annalisa Lonetti, Sabina Chiaretti, Emanuele Valli, Anna Ferrari, Cristina Papayannidis, Francesca Paoloni, Antonella Vitale, Clelia Tiziana Storlazzi, Emanuela Ottaviani, Viviana Guadagnuolo, Sandra Durante, Marco Vignetti, Simona Soverini, Fabrizio Pane, Robin Foà, Michele Baccarani, Markus Müschen, Giovanni Perini & Giovanni Martinelli. (2012) IKAROS Deletions Dictate a Unique Gene Expression Signature in Patients with Adult B-Cell Acute Lymphoblastic Leukemia. PLoS ONE 7:7, pages e40934.
Crossref
Crossref
Kara L. Davis. (2011) Ikaros: master of hematopoiesis, agent of leukemia. Therapeutic Advances in Hematology 2:6, pages 359-368.
Crossref
Crossref
Fen Zhou, Heng Mei, Runming Jin, Xiaoqing Li & Xiangjun Chen. (2011) Expression of Ikaros Isoform 6 in Chinese Children With Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology 33:6, pages 429-432.
Crossref
Crossref
Sudhir Pai Kasturi, Ioanna Skountzou, Randy A. Albrecht, Dimitrios Koutsonanos, Tang Hua, Helder I. Nakaya, Rajesh Ravindran, Shelley Stewart, Munir Alam, Marcin Kwissa, Francois Villinger, Niren Murthy, John Steel, Joshy Jacob, Robert J. Hogan, Adolfo García-Sastre, Richard Compans & Bali Pulendran. (2011) Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470:7335, pages 543-547.
Crossref
Crossref
Olivia L Francis. (2011) Regulator of myeloid differentiation and function: The secret life of Ikaros. World Journal of Biological Chemistry 2:6, pages 119.
Crossref
Crossref
Jerald P. Radich & Olga Sala. 2011. Adult Acute Lymphocytic Leukemia. Adult Acute Lymphocytic Leukemia
25
44
.
Matthias Merkenschlager. (2010) Ikaros in immune receptor signaling, lymphocyte differentiation, and function. FEBS Letters 584:24, pages 4910-4914.
Crossref
Crossref
R Jäger, H Gisslinger, F Passamonti, E Rumi, T Berg, B Gisslinger, D Pietra, A Harutyunyan, T Klampfl, D Olcaydu, M Cazzola & R Kralovics. (2010) Deletions of the transcription factor Ikaros in myeloproliferative neoplasms. Leukemia 24:7, pages 1290-1298.
Crossref
Crossref